0 CHECKOUT

Slovenia Pharmaceuticals and Healthcare Report Q1 2016

  • ID: 3454175
  • November 2015
  • Region: Slovenia
  • 80 pages
  • Business Monitor International
1 of 3

Krka's exposure to Eastern European markets will continue to act as a drag on revenue growth.

However, strong sales growth in Western Europe will mitigate the impact of revenue declines for the short term. We expect a continued focus on cost containment by European healthcare payers to moderate Krka's growth outlook over the longer term, unless the company looks to geographically diversify its exposure.

Headline Expenditure Projections
- Pharmaceuticals: EUR675mn (USD896mn) in 2014 to EUR671mn (USD738mn) in 2015; -0.6% in local currency terms and -17.6% in US dollar terms. Forecasts unchanged compared to previous quarter.

- Healthcare: EUR3.22bn (USD4.27bn) in 2014 to EUR3.23bn (USD3.55bn) in 2015; 0.3% in local currency terms and -16.8% in US dollar terms. Forecasts unchanged compared to previous quarter.

Note: Product cover images may vary from those shown
2 of 3

Table: Headline Pharmaceuticals & Healthcare Forecasts (Slovenia 2013-2019)

SWOT

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Slovenia 2011-2019)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Slovenia 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Slovenia 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Slovenia 2011-2019)

Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Slovenia 2011-2019)

Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Slovenia 2011-2019)

Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Slovenia 2011-2019)

OTC Medicines Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Slovenia 2011-2019)

Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Slovenia 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Slovenia 2013-2019)

Industry Risk Reward Index

Central And Eastern Europe Risk/Reward Index - Q1 2016

Slovenia Risk/Reward Index

Rewards

Risks

Regulatory Review

Intellectual Property Issues

Pricing Regime

Reimbursement Regime

Market Overview

Healthcare Sector
Table: Healthcare Resources (Slovenia 2009-2014)
Table: Healthcare Personnel (Slovenia 2009-2014)
Table: Healthcare Activity (Slovenia 2009-2014)

Research & Development

Clinical Trials

Epidemiology

Competitive Landscape

Research-Based Industry
Table: Table: Multinational Market Activity

Generic Drugmakers

Pharmaceutical Industry Developments

Company Profile

Krka

Lek (Novartis/Sandoz)

Demographic Forecast
Table: Population Headline Indicators (Slovenia 1990-2025)
Table: Key Population Ratios (Slovenia 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Slovenia 1990-2025)
Table: Population By Age Group (Slovenia 1990-2025)
Table: Population By Age Group % (Slovenia 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Cache

Our Clients

  • Pfizer Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S